文献速递肝病

慢加急性肝衰竭:准备迎接主流时刻?

Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?
PubMed 文献 · Hepatology · 2018-09-22

本文综述慢加急性肝衰竭(ACLF)是慢性肝病合并肝外器官衰竭的终末阶段,短期死亡率高且医疗花费巨大;欧洲、北美和亚洲对器官衰竭与ACLF的定义不同,需协调统一;其发病机制涉及免疫炎症系统、微生物群与诱发因素的相互作用,肾、脑、肺、循环等器官衰竭对死亡率有累积不良影响并常合并感染;在人口老龄化和供肝短缺背景下,肝移植作用仍在演变,需大型联合体进一步研究,早期姑息治疗和衰弱管理日益受到认可。

要点

  • ACLF是慢性肝病合并肝外器官衰竭的综合征,短期死亡率高、医疗花费大。
  • 欧洲、北美和亚洲对器官衰竭与ACLF的定义不同,需协调统一以促领域进展。
  • 肾、脑、肺、循环器官衰竭对死亡率有累积不良影响,常合并或由感染诱发。

核心结论

  • ACLF是全球流行的临床相关综合征,需要专注于预后评估和管理的多国协作方法,全球正在开展研究以使ACLF准备迎接主流时刻。

研究设计与样本

  • 本文为综述,未报告系统检索范围。

主要发现

  • ACLF是慢性肝病与肝外器官衰竭的终末阶段,与高短期死亡率和巨大医疗支出相关。
  • 欧洲、北美和亚洲对器官衰竭和ACLF存在不同定义,这些定义需要协调统一。
  • ACLF发病机制为多因素,与免疫炎症系统、微生物群及各种诱发因素之间的相互作用有关。
  • 肾、脑、肺和循环相关个体器官衰竭对死亡率有累积不良影响,且常合并感染或由感染诱发。
  • 在人口老龄化和肝移植供器官短缺背景下,ACLF患者预后差,凸显对新治疗策略的需求。

临床怎么用

  • 预防并快速处理肾、脑、肺和循环器官衰竭对改善生存至关重要。
  • 肝移植在ACLF中的作用正在演变,需在大型联合体中进一步研究。
  • 早期姑息治疗和衰弱管理作为减轻疾病负担、改善患者报告结局的方法日益受到认可。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Acute on chronic liver failure (ACLF) is the culmination of chronic liver disease and extrahepatic organ failures, which is associated with a high short-term mortality and immense health care expenditure. There are varying definitions for organ failures and ACLF in Europe, North America, and Asia. These differing definitions need to be reconciled to enhance progress in the field. The pathogenesis of ACLF is multifactorial and related to interactions between the immunoinflammatory system, microbiota, and the various precipitating factors. Individual organ failures related to the kidney, brain, lungs, and circulation have cumulative adverse effects on mortality and are often complicated or precipitated by infections. Strategies to prevent and rapidly treat these organ failures are paramount in improving survival. With the aging population and paucity of organs for liver transplant, the prognosis of ACLF patients is poor, highlighting the need for novel therapeutic strategies. The role of liver transplant in ACLF is evolving and needs further investigation across large consortia. A role for early palliative care and management of frailty as approaches to alleviate disease burden and improve patient-reported outcomes is being increasingly recognized. CONCLUSION: ACLF is a clinically relevant syndrome that is epidemic worldwide and requires a dedicated multinational approach focused on prognostication and management; investigations are underway worldwide to prepare ACLF for prime time. (Hepatology 2018; 00:000-000).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, Moreau R, Kamath PS, et al. Acute-on-Chronic Liver Failure: Getting Ready for Prime Time? Hepatology. 2018. PMID: 29689120. doi:10.1002/hep.30056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。